Alexander Sparre-Ulrich
Chief Executive Officer at Antag Therapeutics ApS
Alexander Sparre-Ulrich active positions
| Companies | Position | Start | End |
|---|---|---|---|
Antag Therapeutics ApS
 Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Chief Executive Officer | 01/01/2017 | - |
| Founder | 01/01/2017 | - |
Career history of Alexander Sparre-Ulrich
Statistics
International
| Denmark | 2 |
Operational
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Antag Therapeutics ApS
Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Health Technology |
